Henry M. Jackson Foundation for the Advancement of Military Medicine A review article in the New England Journal of Medicine explores the genetic variation of HIV-1 and its implications for preventing ...

Pretreatment drug resistance (PDR) in patients with HIV varies by subtype, affecting antiretroviral therapy implementation and first-line treatment efficacy. In Hangzhou, 8.4% of newly diagnosed HIV ...

The aim of this meta-analysis was to provide a comprehensive overview of human immunodeficiency virus (HIV)-1 subtypes and to investigate temporal and geographical trends of the HIV-1 epidemic among ...

A body mass index (BMI) ≥30 kg/m 2, rilpivirine resistance–associated mutations, and the HIV-1 subtype A6/A1 can raise a person's risk for confirmed virologic failure (CVF) of long-acting cabotegravir ...

To determine whether US residents are infected with subtypes of human immunodeficiency virus (HIV) type 1 other than subtype B (Western), the predominant North American subtype with a unique GPGR ...

A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa - a ...

A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a ...

Mechanisms of HIV persistence and disease. The goal has been to understand how HIV exploits, disrupts, and evades the immune response for replication and persistence in the host. We investigate ...

HIV infection. Computer artwork of HIV particles in the bloodstream. Mosaico trial investigator Dr Stephaun Wallace explains why developing an effective HIV vaccine remains challenging. The phase 3 ...

Ribonucleic acid (RNA) viruses like the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly vulnerable to evolving over time as a result of their error-prone replication process.